Jaime LaMontagne named chief marketing officer of Astrin Biosciences

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Jaime LaMontagne

Jaime LaMontagne was appointed chief marketing officer of Astrin Biosciences. 

LaMontagne was most recently chief marketing officer of Exact Sciences. Prior to Exact Sciences, LaMontagne held senior leadership roles at Medtronic and Smiths Medical (now ICU Medical). 

LaMontagne’s appointment comes as Astrin expands its clinical program for its early cancer detection test for women with dense breasts, which makes up almost half of the female population. Early detection for this patient population is one of the most difficult and expensive cancers to screen. Astrin is planning to launch its first test this fall.

Table of Contents

YOU MAY BE INTERESTED IN

Positive high-level results from the Tropion-Breast02 phase III trial showed Datroway (datopotamab deruxtecan-dlnk) demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival compared to investigator’s choice of chemotherapy as first-line treatment for patients with locally recurrent inoperable or metastatic triple-negative breast cancer for whom immunotherapy was not an option.
From left to right: Geoffrey Shapiro, Leif Ellisen and Nancy Lin. Sitting below them is Kornelia Polyak.The Dana-Farber/Harvard Cancer Center,  a cancer research consortium comprised of five of Boston’s academic medical centers, including Dana-Farber Cancer Institute and Massachusetts General Hospital, has been awarded an NCI grant to continue its Specialized Program of Research Excellence in Breast Cancer.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login